‌

US Patent 11174261 Ectonucleotidase inhibitors and methods of use thereof

Patent 11174261 was granted and assigned to Calithera Biosciences on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Calithera Biosciences

0

Current Assignee

Calithera Biosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Roland J. Billedeau0

Eric B. Sjogren0

Jim Li0

Lijing Chen0

Date of Patent

November 16, 2021

0

Patent Application Number

165851950

Date Filed

September 27, 2019

0

Patent Primary Examiner

Jeffrey H Murray

0

Patent abstract

The invention relates to novel heterocyclic compounds having CD73 inhibitory activity and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11174261 Ectonucleotidase inhibitors and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.